Aspen Neuroscience Insider Trades
NASDAQ: ASPEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 6 · $68.00M
- Sales
- 0 · $0
- Shares bought / sold
- 4.53M / 0
- Net activity
- Net buying $68.0 million
Aspen Neuroscience insider activity
Over the last 12 months, Aspen Neuroscience insiders reported 31 transactions on SEC Form 4: 6 open-market purchases and 0 sales. Insiders bought $68.0 million and sold $0 worth of stock, for net insider buying of $68.0 million. The most recent filing shows Hasnain Faheem (Executive Chair) reporting a transaction in 321,672 shares on Nov 5, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ASPE's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ASPE insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 5, 2026 | Hasnain FaheemExecutive Chair | Award | 321,672 | — | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Buy | 1,200,000 | $18.00M | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Conversion | 214,355 | — | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Conversion | 295,490 | — | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Conversion | 286,304 | — | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Conversion | 298,258 | — | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Buy | 66,667 | $1.00M | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Conversion | 259,948 | — | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Conversion | 295,490 | — | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Conversion | 286,304 | — | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Conversion | 298,258 | — | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Conversion | 187,182 | — | Form 4 |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Partners X, LLC & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN & NELSEN ROBERT10% Owner | Buy | 66,666 | $999.99K | Form 4 |
| Nov 2, 2026 | ARCH Venture Partners XIV, L.P. & ARCH Venture Partners XIV, LLC & ARCH Venture Fund XIV, L.P. & BERNS PAUL L10% Owner | Buy | 1,200,000 | $18.00M | Form 4 |
| Nov 2, 2026 | Spaventa AndrewDirector | Conversion | 180,221 | — | Form 4 |
| Nov 2, 2026 | Spaventa AndrewDirector | Conversion | 70,194 | — | Form 4 |
| Nov 2, 2026 | Hasnain FaheemExecutive Chair | Conversion | 7,120 | — | Form 4 |
| Nov 2, 2026 | Hasnain FaheemExecutive Chair | Conversion | 14,316 | — | Form 4 |
| Nov 2, 2026 | Hasnain FaheemExecutive Chair | Conversion | 14,913 | — | Form 4 |
| Nov 2, 2026 | Thompson Peter A.Director | Buy | 1,000,000 | $15.00M | Form 4 |
| Nov 2, 2026 | Thompson Peter A.Director | Conversion | 507,119 | — | Form 4 |
| Nov 2, 2026 | Thompson Peter A.Director | Conversion | 625,743 | — | Form 4 |
| Nov 2, 2026 | Thompson Peter A.Director | Conversion | 616,984 | — | Form 4 |
| Nov 2, 2026 | Thompson Peter A.Director | Conversion | 642,745 | — | Form 4 |
| Nov 2, 2026 | Thompson Peter A.Director | Conversion | 196,541 | — | Form 4 |
| Nov 2, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirector | Buy | 1,000,000 | $15.00M | Form 4 |
| Nov 2, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirector | Conversion | 507,119 | — | Form 4 |
| Nov 2, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirector | Conversion | 625,743 | — | Form 4 |
| Nov 2, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirector | Conversion | 616,984 | — | Form 4 |
| Nov 2, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirector | Conversion | 642,745 | — | Form 4 |
| Nov 2, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLCDirector | Conversion | 196,541 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4